The Semaglutide Treatment Effect in People With Obesity (STEP) trials have shown the efficacy of semaglutide for the treatment of obesity
Talk to your doctor if you notice an increase in hair loss
With regard to safety concerns, the most prevalent adverse effects associated with GLP-1 RAs are gastrointestinal, such as bloating, dyspepsia, nausea, vomiting, diarrhea and constipation (107)
As a result, many people lose weight quicklyoften 1520% of their body weight in a year
Dietary fiber intake is considered to be one of the most important aspects of not just digestive health, but cardiometabolic health as well
The GLP-1 and GIP components improve insulin secretion and sensitivity, driving blood glucose down